ABSTRACT
Aims
Insomnia affected one‐third of the global population, but its molecular mechanism was not clarified.
Methods
A chronic sleep deprivation (CSD) model was constructed in SD rats using multiple platforms over water. Hippocampal tissues were collected for ubiquitinomics and succinylomics. Sirtuin 7 (SIRT7) inhibitor was administered to elevate succinylation levels. Molecular experiments demonstrated the cascade reaction of succinylation and ubiquitylation, and Neurofilament Light (NFL)‐binding ubiquitinating enzyme.
Results
Chronic sleep deprivation caused cognitive disorder of rats. Mostly, succinylation and ubiquitylation displayed a downregulated trend in the CSD group, especially double modification of NFL at K370 (succinylation site) and K267/281 (ubiquitylation site), whose protein level was upregulated in CSD rats. NFL was proved to be a target of SIRT7, a well‐known desuccinylase. SIRT7 inhibitor weakened cognitive deficit, blocked neuronal apoptosis, decreased NFL expression, and increased succinylation and ubiquitylation levels, which were inverse in the CSD model and cells infected with SIRT7 overexpression adenovirus. SIRT7 suppressed not only succinylation but also ubiquitylation through K370 of NFL. Knockdown of NFL receded cognitive disorder and neuronal apoptosis. BRCA1 Associated Deubiquitinase 1 (BAP1) inhibited NFL ubiquitylation and subsequently degradation.
Conclusion
SIRT7 inhibitor promoted succinylation and cascaded ubiquitylation, as well as disrupting the interaction between BAP1 and NFL, finally suppressing CSD.
Keywords: chronic sleep deprivation, insomnia, NFL, SIRT7, succinylation, ubiquitylation
Chronic sleep deprivation (CSD) caused cognitive deficit and neuronal damage. SIRT7 inhibitor promoted succinylation and ubiquitylation and then induced protein degradation, especially affecting Neurofilament Light (NFL), following reduced cognitive disorder and neuronal apoptosis, eventually inhibiting CSD. Besides, the NFL sites of succinylation (K370) and ubiquitylation (K267/K281) were confirmed.

1. Introduction
Insomnia, a sleep disorder characterized by difficulty initiating or maintaining sleep [1], affects 30%–35% of the global population [2]. It not only causes daytime fatigue and lethargy, but also induces various diseases, such as, cognitive impairment, diabetes, hypertension, cancer, and even death [3]. Pharmacological intervention and cognitive‐behavioral treatments are the two strategies for insomnia [1]. However, different limitations and side effects often lead to unsatisfactory therapeutic outcomes [1, 4]. In modern cultures, chronic sleep deprivation (CSD) is more common than acute sleep deprivation [5], and it accounts for > 50% [1]. Accumulating studies show that CSD is closely associated with cognitive dysfunction [6, 7, 8]. Nevertheless, the molecular mechanisms underlying cognitive decline caused by CSD remain to be revealed.
Post‐translational modifications (PTMs), commonly including phosphorylation, acetylation, methylation, succinylation, and ubiquitylation, regulate protein stability and function and play a crucial role in the development of neurological disorders [9, 10, 11, 12, 13]. Among these PTMs, the effects of phosphorylation [11], acetylation [12], and methylation [13] on CSD have been studied, with the exception of succinylation and ubiquitylation, whose roles remain to be elucidated. Alteration of succinylation has been observed in some diseases related to cognitive impairment, involving Alzheimer's disease [14], ischemic stroke [15], vascular dementia [16] and epilepsy [17], implicating a potential link between succinylation modification and cognitive dysfunction. Dysregulation of ubiquitylation is considered a driver of neurodegenerative diseases [18, 19]. However, little is known about their alterations and functions in CSD. Hu et al. [20] and Chen et al. [21] proposed that altering succinylation affected ubiquitylation in lung adenocarcinoma cells and cardiomyocytes, revealing the existence of causality between succinylation and ubiquitylation. Therefore, this study aimed to investigate their alterations, functions, and relationship in CSD.
Members of the Sirtuin (SIRT) family are widely considered to be the primary catalysts of desuccinylation [22]. Among them, SIRT5 and SIRT7 are better known [23]. They influence the progression of brain diseases or the activity of brain cells either by interfering with the succinylation modification of other factors, or by exerting their effects directly [14, 24, 25, 26]. However, their roles in CSD have yet to be elucidated and require further investigation.
Neurofilament are major cytoskeleton components of the axon and include Neurofilament Light Chain (NFL), Neurofilament Medium Chain (NFM), and Neurofilament Heavy Chain (NFH) [27]. The level of NFL is proportional to the degree of axon damage in various nervous system diseases, such as neurodegenerative, traumatic, and inflammatory diseases [28]. Although higher level of NFL has been observed in both CSD patients [29, 30] and corresponding animal models [31], the functional significance of NFL in this context has yet to be explored. Upregulated NFM in human cerebrospinal fluid is found in a variety of brain diseases, including, progressive supranuclear palsy [32], Alzheimer's disease [33], and frontotemporal dementia [34, 35]. All previous studies suggest that NFL and NFM are increased in a disease environment and may play important roles in neurological diseases. The reason for this increase in brain diseases is worthy of investigation.
In the present study, the changes and roles of succinylation and ubiquitylation PTMs in CSD were explored. The effects of desuccinylase, especially SIRT7, on CSD were proposed and its targets in CSD were defined. Further, the succinylation‐ubiquitylation relationship was detected. The function of NFL on CSD and its combined ubiquitin‐related protein were identified.
2. Materials and Methods
2.1. Animal Experiment Procedure
Nine‐week‐old male Sprague Dawley rats (350 ± 20 g) were purchased from Henan Skobes Biotechnology Co. Ltd. (Anyang, China). All animal experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals and approved by the Laboratory Animal Center of Zhengzhou University (ZZU‐LAC20240419[02]). They were housed in cages with a 12 h light/dark cycle at 22°C ± 1°C and 45%–55% humidity, and allowed to obtain food and water freely. Random numbers were generated using the standard = RAND() function in Microsoft Excel, and the animals were randomly assigned to three experimental parts, with each part further divided into the designated groups. In Part 1, animals were assigned to a SHAM group (12 rats) and a CSD group (12 rats); Part 2 involved four groups (12 rats/group): SHAM, CSD, CSD + SIRT7 inhibitor, and CSD + SIRT5 inhibitor; Part 3 consisted of four groups (12 rats/group): SHAM, CSD, CSD + AAV9‐shNC, and CSD + AAV9‐shNFL. The individual rat was considered as the experimental unit for all animal analyses. After adapting for a week, the CSD model was established with multiple platforms over water, which is the most widely recognized and commonly used method. The water tank contained circular platforms (7 cm in diameter) and the water (22°C–24°C) level was 1 cm below the upper surface of the platforms. When rats approached a state of sleep, muscle relaxation caused them to touch the water, which kept them awake, thereby depriving their sleep. The bigger platforms (12 cm in diameter) were provided for SHAM rats. All animals were placed on the platforms for 20 h, followed by 4 h of rest in cages every day. The timeline was shown in Figure 1A. Next, CSD + SIRT5 inhibitor and CSD + SIRT7 inhibitor groups received intraperitoneal injection with the corresponding inhibitors (SIRT5 inhibitor MC3482 (5 mg/kg) [24] and SIRT7 inhibitor 97,491 (2 mg/kg) [36]; MedChemExpres, Shanghai, China) every day during CSD modeling. During the experimental period, the body weight of rats was recorded. All animals were humanely euthanized under isoflurane anesthesia (2%–3%) by exsanguination.
FIGURE 1.

Chronic sleep deprivation caused learning and memory impairment in rats and changed the succinylomics of rats. (A) The rats were placed on small platform (7 cm in diameter) to cause CSD, while the sham rats were placed on bigger platforms (12 cm in diameter). (B) The body weight of rats in different groups. (C) MWM test was used to measure learning and memory performance. (D) The hippocampal tissue of rats was collected for proteomics analysis. The results represented as mean ± standard deviation (N = 12). Statistical significance was defined as p < 0.05. (E) Volcano plot of differential succinylation proteins between CSD and SHAM group. (F) Heatmap of differential succinylation proteins between CSD and SHAM group. (G) The densities of brain‐specific proteins that were subject to different levels of succinylation were statistically analyzed. (H) Raincloud plot showed the overall changes in the level of succinylation after normalization. (I) Sorted scatter plot exhibited succinylation level of brain specific factors. (J) Analysis of pathogenicity after genetic mutation based on ClinVar database. (K, L) The phosphorylation and succinylation sites of NFL and NFM ( Homo sapiens ) were showed. PhosphoSitePlus website was used for phosphorylation sites exhibition. The protein region referenced Uniport website. (M) The succinylation level of NFL after K370R mutation. The level of differential succinylation was defined as absolute value of log2FC > 1 and p < 0.05. CSD, chronic sleep deprivation; MWM, Morris water maze. NFL, Neurofilament Light Chain; NFM, Neurofilament Medium Chain; K370R, lysine 370 to arginine.
In addition, AAV9‐shNFL was injected into the bilateral hippocampal regions (total 5 μL, 1 × 1012 TU/mL) and the stereotactic coordinates were set as follows: −4.2 mm Anterior–Posterior, ±2.8 mm Medial‐Lateral and −3.5 mm Dorsal‐Ventral. After 14 days of injection, the CSD model was established.
The exclusion criterion was predefined as premature death of an animal that caused the inability to collect behavioral, histological, or molecular data. However, no animals met this criterion, and thus none were excluded from the final analysis. Behavioral tests were performed on 12 rats before sequencing, and n = 6 per group thereafter. Histological and molecular analyses were each performed with n = 6 per group. Sample size was determined based on independent published studies [37, 38] as well as our own laboratory experience. A post hoc power analysis was performed using G*Power software, and the statistical power for all comparisons was ≥ 0.80. All behavioral tests and histological analyses were performed in a blinded manner. In detail, the experimenters responsible for the Morris water maze (MWM) test and image acquisition were unaware of the group assignments. The following parameters were assessed: MWM indicators, Nissl staining, TUNEL/NeuN double immunofluorescence, and molecular analyses of ubiquitination, succinylation, as well as other related molecular alterations.
2.2. MWM Test
The spatial learning/memory was assessed by the MWM test. The escape latency, movement trajectory, velocity, time spent in the target quadrant, and number of platform crossings were recorded. Escape latency was defined as the time required to find the hidden platform.
2.3. Proteomics Analysis
The brain tissues were collected for label‐free proteomics, ubiquitinomics and succinylomics in APPLIED PROTEIN TECHNOLOGY (Shanghai, China) (Figure 1D). Briefly, proteins were extracted, followed by enzymatic digestion and desalting. Modified peptides were enriched using specific antibodies. Following chromatographic separation, the samples were subjected to mass spectrometry analysis. Identification and quantification were carried out with MaxQuant software. The ubiquitylation result and succinylation result were normalized using label‐free data. The level of differential ubiquitylation or succinylation was defined as absolute value of log2FC > 1 and p < 0.05.
2.4. Nissl Staining
The brain sections were hydrated with ethanol in a decreasing concentration gradient, stained with 0.5% cresyl violet for 10 min, and differentiated with 0.25% glacial acetic acid ethanol solution. The staining images were observed under a BX53 microscope (Olympus, Tokyo, Japan).
2.5. NeuN/Terminal Transferase Biotinylated‐dUTP Nick End Labeling (TUNEL) Double Staining and TUNEL Staining
For double staining, brain sections were permeabilized using 0.1% Triton X‐100 for 8 min and then underwent repair in citric acid‐sodium citrate repair solution for 10 min. After incubating with TUNEL‐reaction mixture (Roche, Basel, Switzerland), the sections were blocked with 1% bovine serum albumin (Sangon Biotech, Shanghai, China). Sections were incubated in the NeuN antibody and then incubated with Cy3‐conjugated Goat Anti‐Rabbit IgG(H + L) (Proteintech Group Inc.). The cell nucleus was stained with 4′,6‐diamidino‐2‐phenylindole (Aladdin, Shanghai, China). Images were captured with a microscope.
In Situ Cell Death Detection Kit (Roche) was used for identifying the neuronal apoptotic cells.
2.6. Cell Treatment
The primary hippocampal neurons were obtained from rat hippocampal tissue. In brief, hippocampal tissues were cut into pieces with scissors, digested with trypsin (Solarbio Science & Technology Co. Ltd., Beijing, China), and then cultured in DMEM/F‐12 medium (Biosharp, Hefei, China). The next day, the medium was replaced with Neurobasal containing 2% B27 (Biosharp). Cytarabine was added 3 days later.
The adenoviruses targeting overexpression of SIRT7 and BRCA1 Associated Deubiquitinase 1 (BAP1), knockdown of NFL, along with their corresponding negative controls, were constructed and used to infect the hippocampal neurons. After 24 h, the cells were treated with 5 μM of SIRT7 inhibitor (97,491; GLPBIO, Montclair, CA, USA). The experimental procedure is shown in Figure 4A. Followingly, after 24 h, the cells were treated with Cycloheximide (CHX; Aladdin) or MG132 (Macklin, Shanghai, China) for different time. Neurons were infected with Ad‐myc‐NFL‐WT, Ad‐myc‐NFL‐K371R (succinylation‐losing mutants) or Ad‐myc‐NFL‐K371E (succinylation‐mimicking mutants). After 48 h, neurons were collected for the subsequent experiments.
FIGURE 4.

SIRT7 accelerated neuronal apoptosis and increased the NFL(M) level in vitro. (A) The primary hippocampal neurons were obtained from rat hippocampal tissues and they were infected with Ad‐SIRT7. After 24 h, the cells were treated with SIRT7 inhibitor. (B) PCR and western blot were used to detect the level of SIRT7. (C) The succinylation and ubiquitylation level was detected using western blot assay. (D) IP experiment diagram. The combination between SIRT7 and NFL or NFM. The succinylation (E) and ubiquitylation (G) level of NFL and NFM. (F) The effect of SIRT7 on protein degradation of NFL and NFM. (H) Ubiquitylation level of NFL after altering succinylation. (I, J) The level of NFL and NFM in cell and cellular supernatant was assayed with western blot and ELISA. (K) The neuronal apoptosis was observed with TUNEL staining. (L) Caspase‐3 and Caspase‐9 activity was measured. (M) Western blot was used to detect the level of Bax and Bcl‐2. The results represented as mean ± standard deviation (N = 3). Statistical significance was defined as *p < 0.05. Bax, BCL2 associated X, apoptosis regulator; Bcl‐2, BCL2 apoptosis regulator; ELISA, Enzyme linked immunosorbent assay; NFL, Neurofilament Light Chain; NFM, Neurofilament Medium Chain; PCR, Real‐time polymerase chain reaction; SIRT7, Sirtuin 7; TUNEL, terminal transferase biotinylated‐dUTP nick end labeling.
The 293 T cells were purchased from iCell Bioscience Inc. (Shanghai, China). We constructed plasmids encoding flag‐SIRT7, myc‐NFL, his‐BAP1, myc‐NFL‐K370R (mutation of succinylation site), and myc‐NFL‐K267R/K281R (ubiquitylation site mutation). Cells were transfected with the plasmids and then treated with SIRT7 inhibitor (97491) at 24 h post‐transfection and with MG132 at 48 h post‐transfection.
2.7. Real‐Time Polymerase Chain Reaction (PCR)
Total RNA was extracted from the hippocampal neuron using TRIpure (BioTeke Corporation, Beijing, China). With an All‐in‐One First‐Strand SuperMix (Guangzhou Magen Biotechnology Co. Ltd., Guangzhou, China), reverse transcription of RNA was performed to synthesize cDNA. PCR was carried out using the 2 × Fast Taq plus PCR Master Mix (Biosharp life sciences, Hefei, China) and SYBR Green (Solarbio Science & Technology Co. Ltd.). The results were normalized to β‐actin and were shown as 2−△△CT. SIRT7 forward primer, 5′‐CCCAAACTCTACATTGTGAACC‐3′; SIRT7 reverse primer, 5′‐GCCGAACCAGCCTCCTA‐3′.
2.8. Western Blotting
Tissue and cell samples were lysed with radio immunoprecipitation assay lysis buffer plus 1% common protease inhibitor (Proteintech Group Inc., Wuhan, China). The isolated proteins were quantified using a bicinchoninic acid Protein Assay Kit (Proteintech Group Inc.), separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis, following a transfer onto polyvinylidene fluoride (PVDF) membranes. These PVDF membranes were blocked for 2 h with Western Blot Blocking Buffer (Proteintech Group Inc.) and incubated with primary antibodies, including NFL (Proteintech Group Inc.), NFM (Proteintech Group Inc.), BAP1 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), ubiquitin (Proteintech Group Inc.), SIRT7 (abcepta, Jiangsu, China), Succinyllysine (PTM BIO, Hangzhou, China), BCL2 apoptosis regulator (Bcl‐2) (Proteintech Group Inc.), and BCL2 associated X, apoptosis regulator (Bax) (Proteintech Group Inc.), at 4°C overnight. The secondary antibody (Proteintech Group Inc.) was employed to amplify the signals of the primary antibodies. After developing with an ultrasensitive enhanced chemiluminescence detection kit (Proteintech Group Inc.), the images were obtained by Tanon 5200 Fluorescence Imager (Tanon, Shanghai, China).
2.9. Immunoprecipitation (IP)
Co‐IP kit (Thermo Fisher Scientific Inc., Pittsburgh, PA, USA) was used to detect the succinylation and ubiquitylation levels in tissue and cell samples according to the manufacturer's instructions. The mixture was analyzed by western blotting. In addition to the antibodies mentioned above (in Western blotting section), His‐tag, HA‐tag, and Myc‐tag antibodies (Proteintech Group Inc.) were also used in this analysis.
2.10. Enzyme Linked Immunosorbent Assay (ELISA)
The levels of NFL (Wuhan Fine Biotech Co. Ltd., Wuhan, China) and NFM (Biorbyt, Cambs, UK) in serum and cell supernatant were measured using ELISA according to the manufacturer's detailed instructions.
2.11. Caspase‐3 and Caspase‐9 Activity Measurement
Caspase‐3 Activity Assay Kit and Caspase‐9 Activity Assay Kit were used to detect the Caspase‐3 and Caspase‐9 activity in neurons following the manufacturer's instructions.
2.12. Statistical Analysis
All experimental replicates were performed using independent biological samples. The data were processed using GraphPad Prism Version 9.5.0 and represented as mean ± standard deviation. All data were tested for Normality and Lognormality Tests. Normally distributed data were analyzed using t‐test, one‐way ANOVA or 2‐way ANOVA as appropriate, whereas only the data of “time spent in the target quadrant (Figure 5E)” were analyzed using the Kruskal–Wallis test due to non‐normal distribution. Statistical significance was defined as *p < 0.05.
FIGURE 5.

Neurofilament Light Chain mediated the SIRT7 effect of promoting neuronal apoptosis. (A) The adenoviruses targeting overexpression of SIRT7, knockdown of NFL and corresponding negative control were constructed, and were used to infect the hippocampal neurons. Western blot was used to detect the level of NFL. (B) The neuronal apoptosis was observed with TUNEL staining. (C) Caspase‐3 and Caspase‐9 activity was measured. (D) Western blot was used to detect the level of Bax and Bcl‐2. (E) MWM test was used to measure learning and memory performance. (F) The AAV9‐shNFL was injected into the bilateral hippocampal regions and NFL expression was detected using western blot. The neuronal apoptosis was observed with Nissl staining (G) and NeuN/TUNEL double staining (H). (I) Caspase‐3 and Caspase‐9 activity was measured. (J) Western blot was used to detect the level of Bax and Bcl‐2. (K) The neuronal apoptosis was observed with TUNEL staining. (L) Caspase‐3 and Caspase‐9 activity was measured. (M) Western blot was used to detect the level of Bax and Bcl‐2. The results represented as mean ± standard deviation (N = 3 for cell experiment; N = 6 for animal experiment). Statistical significance was defined as p < 0.05. Bax, BCL2 associated X, apoptosis regulator; Bcl‐2, BCL2 apoptosis regulator; NFL, Neurofilament Light Chain; SIRT7, Sirtuin 7; TUNEL, terminal transferase biotinylated‐dUTP nick end labeling.
3. Results
3.1. CSD Caused Learning and Memory Impairment in Rats
Compared with control rats, those treated with CSD showed a significant decrease in body weight (Figure 1B), suggesting that CSD resulted in body weight loss. In order to observe the impact of CSD on spatial learning and memory in rats, the MWM task was assessed. During the positioning and cruising phase, the escape latency gradually decreased in all rats. A longer time to reach the target platform was observed in the CSD group, compared with the SHAM group (Figure 1C). CSD rats showed slower swimming speed, less time in the target quadrant, and fewer times of crossing platform location than SHAM rats. The above results demonstrate that CSD induces learning and memory deficits in rats.
3.2. CSD Changed the Succinylomics of Rats
Given the crucial role of PTMs in neurological diseases, in this study, we detected PTM changes following CSD. As shown in Figure 1D, hippocampal tissue from CSD and SHAM rats was collected and subsequently subjected to proteomic analysis. Label‐free proteomic analysis revealed altered levels of cell‐type‐specific markers in the brain between SHAM and CSD groups (Figure S1A). These cell markers, including those for astrocytes, oligodendrocytes, and neurons, were obtained from the BrainBase database (https://ngdc.cncb.ac.cn/brainbase/index). The brain‐specific genes downloaded from BrainBase mainly enriched in two functional clusters within our label‐free results. As indicated by different colors in the innermost circle, these clusters were associated with the positive regulation of myelination and regulation of postsynaptic membrane potential. Moreover, within the same cluster, the expression of brain‐specific genes, as indicated by the color in the outermost circle, generally exhibited a unified trend (Figure S1B). Succinylation is a common PTM of protein and plays an important regulatory role in the central nervous system [39]. Thus, succinylation changes in CSD animal samples were detected. Before normalization, nearly half of the proteins were observed to contain only one succinylated site. NFM, TPPP, and NFL exhibited a higher number of succinylated sites among the brain‐specific genes (Figure S1C). The density of the succinylated sites for most factors was 0.002, and the distance between adjacent sites was within 10 amino acids (Figure S1D,E). This low density and middle distance may contribute to modify and alter the protein conformation locally rather than changing its overall structure, thereby minimizing the impact on other protein functions. After normalization with label‐free data, clustering clearly distinguished the model group from the control group. Compared with the SHAM group, 14 proteins exhibited increased succinylation levels, while 59 proteins showed reduced succinylation levels in CSD rats (Figure 1E,F). The overall succinylation levels of brain‐specific factors were decreased in both the SHAM and CSD rats. Notably, the greater density of less than 0 warranted further investigation (Figure 1G). The raincloud plot displayed a greater extent of reduced succinylation levels in CSD rats than SHAM rats (Figure 1H), implying that desuccinylation is associated with the development of CSD. Of note, the succinylation level of more brain‐specific genes was decreased in the CSD group than the SHAM group (Figure 1I). In addition, the relationship between mutation sites in these genes and following pathogenicity was explored based on the Clinvar database (https://www.ncbi.nlm.nih.gov/clinvar/). Most of the mutation sites in Microtubule Associated Protein 1B (MAP1B), which contained the most mutation sites, were benign, whereas the vast majority of mutation sites in NFL were pathogenic (Figure 1J). Further, the structures of NFL and its family member NFM were presented to observe the modification sites on them. As shown in Figure 1K,L, succinylated sites of NFL and NFM were concentrated in the coil areas, and phosphorylation sites were concentrated in the head and tail regions. The location of these PTM sites may be functionally relevant. The findings from the omics analysis were verified in 293 T cells, showing that succinylation of NFL was decreased upon lysine 370 to arginine (K370R) mutation (Figure 1M), which K370 was located within a conserved sequence motif. These findings show that CSD results in alterations in protein succinylation modifications in the rat hippocampus, which in turn affects brain injury.
3.3. SIRT7 Inhibitor Weakened the CSD‐Caused Brain Damage of Rats
Considering that overall succinylation decreased after CSD, we hypothesized that the desuccinylation was enhanced in CSD rats. Therefore, two commercially available and commonly used desuccinylase inhibitors—97,491 (targeting SIRT7) and MC3482 (targeting SIRT5)—were employed in subsequent experiments. As shown in Figure 2A, western blot images suggested that the succinylation level was low in CSD samples and desuccinylase inhibitors potently facilitated the succinylation level. To explore whether succinylation affected the behavioral performance of CSD rats, animals were subjected to the MWM test. In the place navigation test (D1 ~ D5), the escape latency of all rats was decreased over time. A trend for a worse performance was observed in CSD rats in comparison to SHAM rats, while SIRT7 inhibitor treatment shortened the escape latency of CSD animals. In the spatial probe test, CSD treatment reduced the swimming speed, time in the target quadrant, and times of crossing platform location but suppression of SIRT7 effectively reversed these behavioral impairment manifestations (Figure 2B). No difference was observed between the CSD and CSD + SIRT5 inhibitor groups in MWN test. These results indicate that SIRT7 related proteins play more significant roles in CSD development rather than SIRT5 related proteins. Based on HPEPDOCK (http://huanglab.phys.hust.edu.cn/hpepdock/), the combining possibility between desuccinylase (SIRT5 and SIRT7) and brain specific proteins with differentially expressed succinylation levels was measured. All brain‐specific proteins showed stronger binding to SIRT7 than to SIRT5, and among them, NFL exhibited the highest binding affinity for SIRT7 (Figure 2C). These findings further confirm our experimental results that SIRT7 affects CSD by regulating the succinylation of these brain‐specific proteins, and this effect is stronger than that of SIRT5 (Figure 2D). The molecular docking result showed that there was a binding interaction between SIRT7 and NFL (Figure 2E). An exposed K370 site was observed in the 3D structure of NFL (Figure 2F), suggesting that this exposed site facilitates succinylation. In addition, the structure of the K370 site located was conservative based on Consurf (http://consurf.tau.ac.il), indicating its stability across different species and importance for protein function. Further, to study the mechanism by which SIRT7 regulated NFL, the site mutation was used. The succinylation of NFL was weakened when the Lysine (K) at position 370 was mutated to Arginine (R). Overexpression of SIRT7 also inhibited the succinylation of NFL. The succinylation level in NFL wild type (lane 3) and mutant type (lane 4) was similar after SIRT7 overexpression, demonstrating that SIRT7 regulated NFL succinylation via K370 (Figure 2G).
FIGURE 2.

SIRT7 inhibitor weakened the CSD‐caused brain damage of rats. CSD + SIRT5 inhibitor and CSD + SIRT7 inhibitor groups received intraperitoneal injection with the corresponding inhibitors (SIRT5 inhibitor MC3482 and SIRT7 inhibitor 97,491) every day during CSD modeling. (A) The succinylation level was detected using western blot assay. (B) MWM test was used to measure learning and memory performance. (C) Docking energy scores of desuccinylase (SIRT5 and SIRT7) and brain specific protein (rat species). (D) Screening steps for SIRT7. (E) Molecular docking results of NFL ( Homo sapiens ) and SIRT7. This part only showed the region of the core sequence including succinylation site of NFL. (F) The structure and conservation of NFL ( Homo sapiens ) were obtained from Consurf website. (G) The succinylation level of NFL. The neuronal apoptosis was observed with Nissl staining (H) and NeuN/TUNEL double staining (I). (J) Caspase‐3 and Caspase‐9 activity was measured. (K) Western blot was used to detect the level of Bax and Bcl‐2. The results represented as mean ± standard deviation (N = 6 for animal experiment; N = 3 for cell experiment). Statistical significance was defined as p < 0.05. Bax, BCL2 associated X, apoptosis regulator; Bcl‐2, BCL2 apoptosis regulator; CSD, chronic sleep deprivation; MWM, Morris water maze; NFL, Neurofilament Light Chain; SIRT5, Sirtuin 5; SIRT7, Sirtuin 7; TUNEL, terminal transferase biotinylated‐dUTP nick end labeling.
In addition, Nissl staining exhibited that the SHAM neuron was closely arranged, regularly shaped, and uniformly stained. CSD treatment caused neuronal atrophy and neuronal loss, but the SIRT7 inhibitor decreased neuronal loss and morphological alteration (Figure 2H). Further, CSD induced a reduction of NeuN and an increase in the number of TUNEL positive cells, and restraint of SIRT7 attenuated CSD‐caused neuronal apoptosis (Figure 2I). Compared with SHAM rats, increased caspase‐3 and caspase‐9 activity (Figure 2J) and Bax expression, and reduced Bcl‐2 expression (Figure 2K) were observed in CSD rats, while inhibition of SIRT7 reversed these changes of apoptosis related markers (Figure 2J,K). These results prove that CSD leads to protein desuccinylation, and the SIRT7 inhibitor decreases nerve injury in CSD. SIRT7 may combine targeted proteins and reduce their succinylation, especially NFL, thereby aggravating CSD.
3.4. CSD Changed the Ubiquitinomics of Rats
More and more evidence [40, 41, 42] indicates that there is an association between succinylation and ubiquitylation. So, we used the hippocampal tissues to perform the ubiquitinomics detection. According to the volcano plot and heatmap (Figure 3A,B), elevated ubiquitylation levels were observed for 13 proteins, whereas reduced levels were observed for 24 proteins in CSD rats. Similarly, the overall level of brain‐specific protein ubiquitylation was decreased in CSD samples compared with the SHAM group, and the reduction of NFL was the most severe (Figure 3C). IP results verified the ubiquitylation sites identified by ubiquitinomics that K267R/K281R caused the reduction of NFL ubiquitylation (Figure 3D). Next, ubiquitinomics and succinylomics were jointly analyzed. There were 142 sites that underwent only succinylation (green dots) and 109 sites that underwent only ubiquitylation (blue dots). We found that there were 62 sites where succinylation (gray dots) and ubiquitylation (red dots) could occur simultaneously (Figure 3E). The correlation between succinylation and ubiquitylation levels at the same sites was analyzed, indicating no correlation between the two modifications (Figure 3F). Consequently, we explored whether there is a causal relationship between succinylation and ubiquitylation on the same protein. Based on the two PTMs results, we found that NFL and NFM had significantly different levels of succinylation and ubiquitylation among brain‐specific proteins (Figure 3G), and therefore they were recognized as critical factors in CSD. These data imply that CSD changes the ubiquitinomics of the rat hippocampus, and NFL and NFM are the representative factors among modified proteins.
FIGURE 3.

Chronic sleep deprivation changed the ubiquitinomics of rats and SIRT7 inhibitor promoted the succinylation and ubiquitylation in CSD rats. (A) Volcano plot of differential ubiquitylation proteins between CSD and SHAM group. (B) Heatmap of differential ubiquitylation proteins between CSD and SHAM group. (C) Sorted scatter plot exhibited ubiquitylation level of brain specific factors. (D) The ubiquitylation level of NFL. (E) Volcano map displayed brain specific protein succinylation and ubiquitylation. There were 142 sites that only undergo succinylation (green dots), 109 sites that only undergo ubiquitylation (blue dots), and 62 sites where succinylation (gray dots) and ubiquitylation (red dots) could occur simultaneously. (F) The correlation between succinylation level and ubiquitylation level in same sites was analyzed using Spearman Analysis. (G) The proteomics results of brain specific proteins with both differential succinylation and ubiquitylation at non‐overlapping sites. The level of differential ubiquitylation was defined as absolute value of log2FC > 1 and p < 0.05. (H, I) The succinylation and ubiquitylation level of NFL and NFM. (J) Western blotting was used to measure the NFL and NFM protein expression. (K) The blood samples from the rats were collected for the NFL and NFM level detection using ELISA. The results represented as mean ± standard deviation (N = 6). Statistical significance was defined as p < 0.05. CSD, chronic sleep deprivation; ELISA, Enzyme linked immunosorbent assay; NFL, Neurofilament Light Chain; NFM, Neurofilament Medium Chain; SIRT7, Sirtuin 7.
3.5. SIRT7 Inhibitor Promoted the Succinylation and Ubiquitylation in CSD Rats
In order to determine the causality between succinylation and ubiquitylation, the level of NFL and NFM and their modifications were examined. IP results demonstrated that succinylation and ubiquitylation levels of NFL and NFM in CSD samples were downregulated but upregulated in the SIRT7 inhibitor‐treated group (Figure 3H,I), hinting that enhancement of succinylation promoted the ubiquitylation. CSD increased the expression of NFL and NFM in the hippocampal region of the rat brain tissues and in the serum. By contrast, these enhancements were weakened after SIRT7 inhibitor management (Figure 3J,K). This assumption was verified that the desuccinylation caused by SIRT7 reduces the ubiquitylation of NFL(M) and causes their expression stabilization.
3.6. SIRT7 Accelerated Neuronal Apoptosis and Inhibited the Succinylation and Ubiquitylation In Vitro
The PCR and western blot results showed that hippocampal neuron was infected with Ad‐SIRT7 successfully (Figure 4B). Next, the effect of SIRT7 in vitro was verified. SIRT7 reduced the succinylation and ubiquitylation, and SIRT7 inhibitor increased these double modifications (Figure 4C). Further, IP results revealed that SIRT7 combined with NFL and NFM (Figure 4D). The lower succinylation and ubiquitylation of NFL and NFM were observed in Ad‐SIRT7 neuron rather than cells with SIRT7 suppression (Figure 4E,G). With the extension of time, SIRT7 restrained the degradation of NFL and NFM, and inhibition of SIRT7 promoted degradation. The effect of SIRT7 on NFL appeared to be greater than that on NFM (Figure 4F). The ubiquitylation of NFL was weakened when cells were transfected succinylation‐inactive mutant. Overexpression of SIRT7 also inhibited the ubiquitylation of NFL. These results suggest that decrease of succinylation also weakened ubiquitylation. In the context of SIRT7 overexpression, no significant difference in NFL ubiquitylation levels was observed between wild‐type and mutant cells. These findings further confirm that SIRT7 regulates NFL succinylation via K370 and then influence ubiquitylation (Figure 4H). We also observed that higher levels of NFL and NFM were present in Ad‐SIRT7 neurons rather than in cells with SIRT7 suppression (Figure 4I,J). Overexpression of SIRT7 resulted in neuronal apoptosis and inhibition of SIRT7 reduced TUNEL‐positive cells (Figure 4K). Higher caspase‐3 activity, caspase‐9 activity and Bax expression, and lower Bcl‐2 expression were found in Ad‐SIRT7 cells than Ad cells (Figure 4L,M). Ad‐SIRT7‐infected cells treated with the SIRT7 inhibitor exhibited a significant reduction in apoptotic factors and an increase in Bcl‐2 (Figure 4L,M). These results indicate that SIRT7 may inhibit succinylation and following ubiquitylation, and then stable protein expression of NFL and NFM, eventually causing neuronal apoptosis.
3.7. NFL Mediated the SIRT7 Effect of Promoting Neuronal Apoptosis
Based on our findings, SIRT7 treatment ultimately led to an increase of NFL in the protein level. Further rescue experiments demonstrate whether NFL mediates neuronal apoptosis caused by SIRT7. The NFL protein level was upregulated in Ad‐SIRT7 cells and downregulated in Ad‐SIRT7 cells upon co‐infection with Ad‐shNFL, suggesting that adenovirus infection was effective (Figure 5A). Increased apoptosis was observed in overexpression of SIRT7 cells, as evidenced by more TUNEL‐positive cells (Figure 5B), higher caspase‐3 and caspase‐9 activity (Figure 5C), greater Bax expression and lesser Bcl‐2 expression (Figure 5D). These data demonstrate that NFL mediated the SIRT7 effect on neuronal apoptosis. After knockdown of NFL, the neuronal apoptosis was inhibited (Figure 5B–D). Moreover, the effect of NFL was verified in a rat model. CSD induced a reduction of spatial learning ability and memory retention ability while shNFL reversed the decline in behavior (Figure 5E). Western blotting results displayed that AAV9‐shNFL markedly reduced the NFL expression in rat hippocampus (Figure 5F). Abnormal neuronal morphology and massive apoptosis were found in CSD rats, and NFL silencing maintained the normal shape and survival of neurons (Figure 5G,H). Increased caspase‐3 and caspase‐9 activity, Bax level, and decreased Bcl‐2 level were found in the hippocampus of CSD rats (Figure 5I,J), whereas knockdown of NFL inhibited these alterations (Figure 5I,J). These results indicate that SIRT7 exerts a damaging effect on neurons and aggravates CSD via NFL.
Above findings showed that NFL mediated SIRT7 effect and K370 was the active site. To verify whether the mutation at this site would have any effect on neuronal apoptosis, we infected the rat neurons with the mutants. NFL‐K371R represents the loss of succinylation and NFL‐K371E (Glutamic acid) indicates mimicking succinylation. Compared with Vector, increased myc‐NFL expression was observed in Ad‐myc‐NFL‐WT cells, suggesting the successful infection of adenovirus. Higher myc‐NFL level was shown in K371R cells and lower level was found in K371E cells than WT cells, suggesting that succinylation promoted ubiquitylation‐degradation of NFL (Figure S2). Stronger TUNEL staining, elevated caspase‐3 and caspase‐9 activity, enhanced Bax expression, and reduced Bcl‐2 expression were displayed in overexpression NFL cells (Figure 5K–M), compared with vector. K371R promoted neuronal apoptosis, as evidenced by upregulated TUNEL+ cells, caspase‐3 activity, caspase‐9 activity, and Bax level, and downregulated Bcl‐2 level, while K371E inhibited neuronal apoptosis (Figure 5K–M). These findings imply that forced succinylation protects neuron.
3.8. NFL Might Be Stabilized by BAP1, a Deubiquitinating Enzyme
Additionally, we also explored enzymes that can affect ubiquitylation of NFL. Using database UALCA (https://ualcan.path.uab.edu/index.html), 486 proteins involved in ubiquitylation were identified; meanwhile, database BioGrid (https://thebiogrid.org/) filtered 157 proteins that interacted with NFL. Overlap analysis via Venn diagram identified 10 proteins that were potentially involved in NFL ubiquitylation. Following alphabetical ordering from A to Z, BAP1 was prioritized for validation in this study (Figure 6A). We queried each of these factors individually. PARK2, TRIM55, TRIM63, and TRAF4 were found to be barely expressed in neurons (https://www.proteinatlas.org/), while PIAS4, RSPRY1, and PSMD14 had no studied involvement in ubiquitination (https://pubmed.ncbi.nlm.nih.gov/). Of the remaining three factors (TRAF7, USP2, and BAP1), only BAP1 was likely to be co‐expressed with NFL in cells (https://www.genecards.org/). Molecular docking analysis using HDOCK SERVER (http://hdock.phys.hust.edu.cn/) revealed an interaction between BAP1 and NFL (Figure 6B). The combination between NFL and BAP1 was verified through Co‐IP (Figure 6C). Next, the effect of BAP1 on NFL protein was detected. Western blot results showed that hippocampal neuron was infected with Ad‐BAP1 successfully (Figure 6D). With increasing treatment time of CHX, NFL protein was degraded; however, this degradation was effectively inhibited by Ad‐BAP1 (Figure 6E). Compared with control, overexpression of BAP1 reduced ubiquitylation level of NFL and stabilized its expression (Figure 6F). Mutation of the ubiquitylation sites (K267R/K281R) abrogated ubiquitylation, resulting in increased stability of NFL protein. Concurrently, the interaction between NFL and BAP1 (a deubiquitinase) was abolished (Figure 6G). The above results demonstrate that BAP1 causes deubiquitylation of NFL and stabilizes it.
FIGURE 6.

Neurofilament Light Chain might be stabilized by BAP1, a deubiquitinating enzyme. (A) Venn diagram showed ubiquitylation‐related proteins that were interacted with NFL. (B) Molecular docking analysis using HDOCK SERVER (http://hdock.phys.hust.edu.cn/). (C) The combine between NFL and BAP1 was verified using Co‐IP. (D) Western blot was used to detect the level of BAP1. (E) NFL protein stability was measured by western blotting. (F) The effect of BAP1 on ubiquitylation level of NFL was assessed. (G–J) Co‐IP detected the interaction between NFL and BAP1 in different groups.
The relationship between deubiquitylation and succinylation was studied. When succinylation was inhibited (CSD group), the interaction between BAP1 and NFL was increased (Figure 6H). Overexpression of SIRT7 enhanced the combination between BAP1 and NFL while inhibition of SIRT7 weakened this interaction (Figure 6I). The combination between BAP1 and NFL was increased after succinylation was abrogated via K370R (Figure 6J). These results suggest that succinylation may disturb the combination between NFL and deubiquitinating enzyme.
4. Discussion
In this study, we found that CSD causes cognitive impairment. Succinylation and ubiquitylation are decreased in CSD, and SIRT7 inhibitor administration reverses the damage caused by CSD. SIRT7 accelerates the desuccinylation and subsequent ubiquitylation reduction of NFL and NFM.
Sleep is a fundamental behavior for humans and necessary for the maintenance of physical health including cognitive function [43]. Insomnia impairs brain and stress immune pathways causing mental disorders [44]. Many animal models are developed and applied in CSD study, such as multiple platforms over water, rotating drum, gentle touch, orbital shaker and novel environment [45]. The multiple platforms over water method, which is the most widely used model for CSD [46], was used in our study. Several previous studies suggested that 7 days of CSD [47], 21 days of CSD [48], and 8 weeks of CSD [49] led to enhanced neuronal apoptosis and cognitive impairment. The body weight reduction in CSD animals was observed in previous studies [46, 47]. In line with these studies, we also found that CSD treatment declined the body weight, spatial learning/memory and increased the neuronal injury and apoptosis. The SHAM rats and the CSD rats were able to freely access sufficient food and water. In this context, the weight loss in the model group might be attributed to (1) the anorexic reaction caused by insufficient sleep leading to reduced food intake and (2) increased energy consumption. Previous studies supported our conjecture. Radcliffe et al. proposed that severe sleep restriction suppressed appetite in a randomized controlled trial [50]. Sleep deprivation of rats caused hypothalamic–pituitary–adrenal axis activation and then increased energy expenditure [51].
Next, we collected hippocampal tissues to explore the molecular mechanism. Total‐succinylation and ubiquitylation decreases were found in CSD samples. The majority of brain‐specific proteins exhibited reduced levels of PTMs in this paper. A growing number of studies certify that genetic mutations are related to the progression of brain diseases [52, 53, 54, 55]. Therefore, we presented the information regarding the pathogenicity of mutations in brain‐specific proteins. NFL, which has the largest number of pathogenic sites, attracted our attention. Meanwhile, succinylation and ubiquitylation of NFM, which belongs to the same family as NFL, were also downregulated. Considering that most studies on PTMs of the neurofilament family have focused on phosphorylation [27, 56, 57, 58], we acquired the phosphorylation sites and succinylation sites of NFL and NFM in order to discover internal connections. Phosphorylation is related to the functions and degradation of proteins in the neurofilament family [27, 56, 57]. Hyperphosphorylation leads to abnormal accumulation of protein [56]. The degradation incidence of dephosphorylated neurofilament proteins was higher than that of phosphorylated neurofilament proteins, exhibiting a faster degradation rate and a greater degradation extent [58]. In this paper, protein expression of NFL and NFM was higher when succinylation and ubiquitylation were inhibited under CSD treatment. In other words, succinylation and ubiquitylation caused NFL and NFM protein degradation, which may be different from phosphorylation. This difference might be attributed to the different structural regions in which these sites are located.
In addition, the potential effect on CSD of other proteins, which had the differently changing level of PTMs based on our results, was also searched. We speculated that the observed protein changes may be associated with PTMs and thereby affect function. Pyruvate carboxylase (PC) was conducive to the tricarboxylic acid cycle and then reduced cognitive impairments in chronic sleep fragmentation mouse [59]. The increased succinylation of PC was found in our succinylomics results. Sleep deprivation increased Cytochrome C Oxidase Subunit 4I1 (COX4I1) [60], Protein Phosphatase 2 Scaffold Subunit alpha (PPP2R1A) [61], Glial Fibrillary Acidic Protein (GFAP) [62] protein expression, suggesting that their PTMs might be changed after sleep deprivation. Lower COX4I1, PPP2R1A, and GFAP succinylation levels were observed in CSD samples than SHAM rats. Glutamate Ionotropic Receptor AMPA Type Subunit 1 (GRIA1) knockout mice showed longer waking than wild type mice [63], suggesting that GRIA1 was reduced when sleep deprivation occurred. Mahogunin Ring Finger 1 (MGRN1) monoubiquitylation decreased its expression and then impaired the cognitive performance of animals [64]. Similarly, in cognitive dysfunction CSD rats, the increased ubiquitylation of GRIA1 and MGRN1 was observed. A clinical trial demonstrated that the C‐Reactive Protein (CRP) concentrations were increased in sleep deprivation subjects [65]. Growth Associated Protein 43 (GAP43) was increased in sleep deprivation [66]. Above findings indicated that in sleep deprivation, the ubiquitylation degradation of CRP and GAP43 may be reduced. Based on our ubiquitinomics results, the lower ubiquitylation of CRP and GAP43 was found in CSD samples. Our findings display that CSD may induce brain damage via the above mentioned proteins with succinylation and ubiquitylation.
We found that inhibition of succinylation was observed in CSD samples, hinting that succinylation might resist CSD. The following experiments were carried out to verify this presumption. First of all, SIRT7 inhibitor was applied to promote succinylation, and following improved behavioral indicators, normalized neurons and decreased apoptosis were observed after succinylation enhancement. Conversely, CSD rats and Ad‐SIRT7 cells exhibited cognitive disorder, abnormal neurons, and upregulated apoptosis. The relationship between succinylation and other neurological diseases, and SIRT7 and cognition were published in the previous studies. Desuccinylation caused microglial overactivation and excessive release of proinflammatory cytokines, eventually leading to neuronal cell damage in stroke [15]. Knockdown of SIRT7 inhibited cell apoptosis in Alzheimer's disease [67]. However, their interaction in CSD was not clear. Notably, in CSD samples, we found that after restoring succinylation with SIRT7 inhibitor, CSD induced brain damage was suppressed, revealing that succinylation weakens CSD.
The website predicted a closer integration between SIRT7 and NFL. The exposed 370 site increased the possibility of succinylation, and the conservative structure implied that this functional area showed stability across different species. The following IP experiments verified the combination of SIRT7 with NFL (M). Based on the label‐free results, NFL and NFM were the factors most significantly altered by succinylation and ubiquitylation. Therefore, NFL and NFM were used as the downstream of SIRT7. Lower PTMs levels of NFL and NFM were observed in CSD samples, while their protein expressions were increased in the CSD group, implying that the level of protein modification was inversely proportional to the amount of protein. SIRT7 adenovirus administration inhibited NFL and NFM succinylation and ubiquitylation‐mediated degradation, while repression of SIRT7 promoted their succinylation and ubiquitylation. These findings were similar to the preceding studies that blocking succinylation decreased the ubiquitylation of the corresponding protein, ultimately stabilizing protein expression [21, 68]. The mutation test indicated that corresponding site mutations inhibit the corresponding modifications, which corroborated the accuracy of our modification proteomics results from a different perspective. We further found that SIRT7 reduced the succinylation and ubiquitylation of NFL via K370. Cells transfected with succinylation‐inactive mutant (K370R) or SIRT7 adenovirus showed reduced NFL ubiquitylation levels, suggesting the existence of causality between succinylation and ubiquitylation. The increased NFL and NFM was related to impaired cognitive function in Alzheimer disease [33, 69] and schizophrenia [70]. Overexpression of NFL increased neuronal apoptosis [71, 72]. In this study, weakened neuronal apoptosis was observed when NFL and NFM protein expressions were reduced using the SIRT7 inhibitor, in vivo and in vitro. The rescue experiment demonstrated that NFL mediated SIRT7‐caused neuron damage and CSD development. We also found that the succinylation‐mimicking mutant (K → E) caused neuronal apoptosis while the inactive mutant (K → R) inhibited apoptosis, indicating that NFL succinylation cascades its ubiquitylation‐degradation and suppresses apoptosis. Although our data revealed that NFL exerts effects on CSD rats and that succinylation mutants influence neuronal apoptosis, additional in vivo studies are required to determine whether these mutants confer similar effects in CSD rats in the future. The exact function of NFM on CSD also warrants further investigation.
In addition, we also investigated the ubiquitinases who affected NFL stability. The relationship between NFL and BAP1 was first reported. BAP1 is a member of the ubiquitin C‐terminal hydrolases family and functions as a deubiquitinating enzyme [73]. BAP1 promoted lipid peroxidation, ferroptosis, neuronal apoptosis and neurological dysfunction via directly binding to substrate protein and then inhibiting their ubiquitylation [73, 74]. In this paper, we found that BAP1 interacted with NFL and reduced its ubiquitylation degradation. Succinylation weakened the combination between BAP1 and NFL. It suggests that BAP1 stabilizes NFL protein expression and aggravates neuron damage. Campagne et al. put forward that BAP1 C91S was a catalytically dead version [75], however, in this study, we have not yet utilized this mutation to determine whether BAP1 is a specific deubiquitinating enzyme for NFL. There are also some other limitations for our study, for example, BAP1 activity changes in vivo model are not examined and no in vivo experiments with BAP1 knockdown or pharmacological inhibition to determine its contribution to NFL stabilization and CSD pathology. These questions will be addressed in future studies.
5. Conclusion
Overall, CSD caused cognitive deficit and neuronal damage. SIRT7 inhibitor promoted succinylation and ubiquitylation, and then induced protein degradation, especially affecting NFL and NFM, following reduced cognitive disorder and neuronal apoptosis, eventually inhibiting CSD. Besides, the NFL sites of succinylation (K370) and ubiquitylation (K267/K281) were confirmed. SIRT7 inhibited NFL succinylation via K370 and then influenced ubiquitylation. Knockdown of NFL receded cognitive disorder and neuronal apoptosis. BAP1 inhibited ubiquitylation of NFL while succinylation weakened their combination. Our study fills the gap in the roles of succinylation, ubiquitylation, SIRT7 inhibitor, and NFL on CSD. These findings contribute to the development of specific inhibitors.
Author Contributions
Wenkai Yu: conceptualization, mthodology, investigation, witing – original draft; Xinyu Li: conceptualization, data curation, writing – original draft; Chan Zhang: methodology, investigation; Pengpeng Niu: methodology, investigation; Zhihua Yang: methodology, investigation; Wenjun He: data curation; Kai Gao: data curation; Yihan Wei: data curation; Yuming Xu: conceptualization, writing – review and editing; Yusheng Li: conceptualization, writing – review and editing. All authors read and approved the final manuscript.
Funding
This work was supported by National Natural Science Foundation of China (82571620) & (82171300).
Ethics Statement
All animal experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals and approved by the Laboratory Animal Center of Zhengzhou University (ZZU‐LAC20240419[02]).
Consent
The authors have nothing to report.
Conflicts of Interest
The authors declare no conflicts of interest.
Supporting information
Figure S1: CSD changed the succinylomics of rats.
Figure S2: Western blot was used to detect the level of myc‐NFL.
Acknowledgments
The authors have nothing to report.
Contributor Information
Yuming Xu, Email: xuyuming@zzu.edu.cn.
Yusheng Li, Email: fccliyusheng@zzu.edu.cn.
Data Availability Statement
The Proteomics analysis results were deposited in the PRoteomics IDEntifications Database (PRIDE, https://www.ebi.ac.uk/pride/). The accession numbers included PXD071915 (label‐free proteomics), PXD071510 (ubiquitinomics), and PXD071630 (succinylomics).
References
- 1. Buysse D. J., “Insomnia,” JAMA 309, no. 7 (2013): 706–716, 10.1001/jama.2013.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Morin C. M., Drake C. L., Harvey A. G., et al., “Insomnia Disorder,” Nature Reviews. Disease Primers 1, no. 1 (2015): 15026, 10.1038/nrdp.2015.26. [DOI] [PubMed] [Google Scholar]
- 3. Sadeghmousavi S., Eskian M., Rahmani F., and Rezaei N., “The Effect of Insomnia on Development of Alzheimer's Disease,” Journal of Neuroinflammation 17, no. 1 (2020): 289, 10.1186/s12974-020-01960-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Yin C., Zhang M., Jin S., et al., “Mechanism of Salvia miltiorrhiza Bunge Extract to Alleviate Chronic Sleep Deprivation‐Induced Cognitive Dysfunction in Rats,” Phytomedicine 130 (2024): 155725, 10.1016/j.phymed.2024.155725. [DOI] [PubMed] [Google Scholar]
- 5. Basner M., Rao H., Goel N., and Dinges D. F., “Sleep Deprivation and Neurobehavioral Dynamics,” Current Opinion in Neurobiology 23, no. 5 (2013): 854–863, 10.1016/j.conb.2013.02.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Kim D. Y., Kim S.‐M., and Han I.‐O., “Chronic Rapid Eye Movement Sleep Deprivation Aggravates the Pathogenesis of Alzheimer's Disease by Decreasing Brain O‐GlcNAc Cycling in Mice,” Journal of Neuroinflammation 21, no. 1 (2024): 180, 10.1186/s12974-024-03179-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Wang W., Wang Z., Cao J., Dong Y., and Chen Y., “Melatonin Ameliorates Chronic Sleep Deprivation Against Memory Encoding Vulnerability: Involvement of Synapse Regulation via the Mitochondrial‐Dependent Redox Homeostasis‐Induced Autophagy Inhibition,” Free Radical Biology & Medicine 225 (2024): 398–414, 10.1016/j.freeradbiomed.2024.10.279. [DOI] [PubMed] [Google Scholar]
- 8. Lu C., Wei Z., Jiang N., et al., “Soy Isoflavones Protects Against Cognitive Deficits Induced by Chronic Sleep Deprivation via Alleviating Oxidative Stress and Suppressing Neuroinflammation,” Phytotherapy Research 36, no. 5 (2022): 2072–2080, 10.1002/ptr.7354. [DOI] [PubMed] [Google Scholar]
- 9. Yang Y. and Gibson G. E., “Succinylation Links Metabolism to Protein Functions,” Neurochemical Research 44, no. 10 (2019): 2346–2359, 10.1007/s11064-019-02780-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Yang Y., Tapias V., Acosta D., et al., “Altered Succinylation of Mitochondrial Proteins, APP and Tau in Alzheimer's Disease,” Nature Communications 13, no. 1 (2022): 159, 10.1038/s41467-021-27572-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Ren H., Lu M., Zhang D., Xing Y., and Chen Z., “Chronic Sleep Deprivation Promotes Experimental Autoimmune Uveitis Through STAT1 Phosphorylation, ISG15 Expression and Enhanced Pathogenicity of Macrophages,” International Immunopharmacology 154 (2025): 114556, 10.1016/j.intimp.2025.114556. [DOI] [PubMed] [Google Scholar]
- 12. Li J., Liu Y., Liao Z., et al., “Targeting the YY1/HDAC2 Transcriptional Axis by Neferine Ameliorates Sleep Deprivation‐Induced Cognitive Deficits,” Neurochemical Research 51, no. 1 (2026): 37, 10.1007/s11064-025-04651-0. [DOI] [PubMed] [Google Scholar]
- 13. Xing F., Shi X. S., Gu H. W., et al., “METTL3‐Mediated m(6)A Modification Regulates CDKN1A to Attenuate Chronic Sleep Deprivation‐Induced Cognitive Impairment and Neuronal Apoptosis in Rats,” Translational Psychiatry 16, no. 1 (2026): 96, 10.1038/s41398-026-03855-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Deng P., Fan T., Gao P., et al., “SIRT5‐Mediated Desuccinylation of RAB7A Protects Against Cadmium‐Induced Alzheimer's Disease‐Like Pathology by Restoring Autophagic Flux,” Advanced Science 11, no. 30 (2024): e2402030, 10.1002/advs.202402030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Xia Q., Gao S., Han T., et al., “Sirtuin 5 Aggravates Microglia‐Induced Neuroinflammation Following Ischaemic Stroke by Modulating the Desuccinylation of Annexin‐A1,” Journal of Neuroinflammation 19, no. 1 (2022): 301, 10.1186/s12974-022-02665-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Wang H., Lu J., Gao W. C., et al., “Donepezil Down‐Regulates Propionylation, 2‐Hydroxyisobutyrylation, Butyrylation, Succinylation, and Crotonylation in the Brain of Bilateral Common Carotid Artery Occlusion‐Induced Vascular Dementia Rats,” Clinical and Experimental Pharmacology & Physiology 47, no. 10 (2020): 1731–1739, 10.1111/1440-1681.13352. [DOI] [PubMed] [Google Scholar]
- 17. Aleshin V. A., Graf A. V., Artiukhov A. V., et al., “Pentylenetetrazole‐Induced Seizures Are Increased After Kindling, Exhibiting Vitamin‐Responsive Correlations to the Post‐Seizures Behavior, Amino Acids Metabolism and Key Metabolic Regulators in the Rat Brain,” International Journal of Molecular Sciences 24, no. 15 (2023): 12405, 10.3390/ijms241512405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Hiskens M. I., “Glua1 Ubiquitination in Synaptic Plasticity and Cognitive Functions: Implications for Neurodegeneration,” Journal of Neuroscience 44, no. 3 (2024): e2018232024, 10.1523/JNEUROSCI.2018-23.2024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Guntupalli S., Park P., Han D. H., et al., “Ubiquitination of the GluA1 Subunit of AMPA Receptors Is Required for Synaptic Plasticity, Memory, and Cognitive Flexibility,” Journal of Neuroscience 43, no. 30 (2023): 5448–5457, 10.1523/JNEUROSCI.1542-22.2023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Hu Q., Xu J., Wang L., et al., “SUCLG2 Regulates Mitochondrial Dysfunction Through Succinylation in Lung Adenocarcinoma,” Advanced Science 10, no. 35 (2023): e2303535, 10.1002/advs.202303535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Chen Y., Wu G., Li M., et al., “LDHA‐Mediated Metabolic Reprogramming Promoted Cardiomyocyte Proliferation by Alleviating ROS and Inducing M2 Macrophage Polarization,” Redox Biology 56 (2022): 102446, 10.1016/j.redox.2022.102446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Yuan H. F., Zhao M., Zhao L. N., et al., “PRMT5 Confers Lipid Metabolism Reprogramming, Tumour Growth and Metastasis Depending on the SIRT7‐Mediated Desuccinylation of PRMT5 K387 in Tumours,” Acta Pharmacologica Sinica 43, no. 9 (2022): 2373–2385, 10.1038/s41401-021-00841-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Shen R., Ruan H., Lin S., et al., “Lysine Succinylation, the Metabolic Bridge Between Cancer and Immunity,” Genes & Diseases 10, no. 6 (2023): 2470–2478, 10.1016/j.gendis.2022.10.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Xia Q., Yu Y., Zhan G., et al., “The Sirtuin 5 Inhibitor MC3482 Ameliorates Microglia‑Induced Neuroinflammation Following Ischaemic Stroke by Upregulating the Succinylation Level of Annexin‐A1,” Journal of Neuroimmune Pharmacology 19, no. 1 (2024): 17, 10.1007/s11481-024-10117-x. [DOI] [PubMed] [Google Scholar]
- 25. Alnoud M. A. H., Chen W., Liu N., et al., “Sirt7‐p21 Signaling Pathway Mediates Glucocorticoid‐Induced Inhibition of Mouse Neural Stem Cell Proliferation,” Neurotoxicity Research 39, no. 2 (2021): 444–455, 10.1007/s12640-020-00294-x. [DOI] [PubMed] [Google Scholar]
- 26. Ou Z., Wang Y., Yao J., et al., “Astragaloside IV Promotes Angiogenesis by Targeting SIRT7/VEGFA Signaling Pathway to Improve Brain Injury After Cerebral Infarction in Rats,” Biomedicine & Pharmacotherapy 168 (2023): 115598, 10.1016/j.biopha.2023.115598. [DOI] [PubMed] [Google Scholar]
- 27. Petzold A., “Neurofilament Phosphoforms: Surrogate Markers for Axonal Injury, Degeneration and Loss,” Journal of the Neurological Sciences 233, no. 1–2 (2005): 183–198, 10.1016/j.jns.2005.03.015. [DOI] [PubMed] [Google Scholar]
- 28. Gaetani L., Blennow K., Calabresi P., Di Filippo M., Parnetti L., and Zetterberg H., “Neurofilament Light Chain as a Biomarker in Neurological Disorders,” Journal of Neurology, Neurosurgery, and Psychiatry 90, no. 8 (2019): 870–881, 10.1136/jnnp-2018-320106. [DOI] [PubMed] [Google Scholar]
- 29. Ren C.‐Y., Liu P.‐P., Li J., et al., “Changes in Telomere Length and Serum Neurofilament Light Chain Levels in Female Patients With Chronic Insomnia Disorder,” Journal of Clinical Sleep Medicine 18, no. 2 (2022): 383–392, 10.5664/jcsm.9574. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Zhang P., Tan C.‐W., Chen G.‐H., et al., “Patients With Chronic Insomnia Disorder Have Increased Serum Levels of Neurofilaments, Neuron‐Specific Enolase and S100B: Does Organic Brain Damage Exist?,” Sleep Medicine 48 (2018): 163–171, 10.1016/j.sleep.2017.12.012. [DOI] [PubMed] [Google Scholar]
- 31. Liu S., Zhang Z., Shi S., et al., “NREM Sleep Loss Increases Neurofilament Light Chain Levels in APP/PS1 and C57BL/6 J Mice,” Sleep & Breathing 27, no. 4 (2023): 1495–1504, 10.1007/s11325-022-02719-7. [DOI] [PubMed] [Google Scholar]
- 32. Jang Y., Oh S., Hall A. J., et al., “Biomarker Discovery in Progressive Supranuclear Palsy From Human Cerebrospinal Fluid,” Clinical Proteomics 21, no. 1 (2024): 56, 10.1186/s12014-024-09507-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Bergström S., Remnestål J., Yousef J., et al., “Multi‐Cohort Profiling Reveals Elevated CSF Levels of Brain‐Enriched Proteins in Alzheimer's Disease,” Annals of Clinical Translational Neurology 8, no. 7 (2021): 1456–1470, 10.1002/acn3.51402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Barschke P., Oeckl P., Steinacker P., et al., “Different CSF Protein Profiles in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia withC9orf72hexanucleotide Repeat Expansion,” Journal of Neurology, Neurosurgery, and Psychiatry 91, no. 5 (2020): 503–511, 10.1136/jnnp-2019-322476. [DOI] [PubMed] [Google Scholar]
- 35. Bergström S., Öijerstedt L., Remnestål J., et al., “A Panel of CSF Proteins Separates Genetic Frontotemporal Dementia From Presymptomatic Mutation Carriers: A GENFI Study,” Molecular Neurodegeneration 16, no. 1 (2021): 79, 10.1186/s13024-021-00499-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Kim J. H., Kim D., Cho S. J., et al., “Identification of a Novel SIRT7 Inhibitor as Anticancer Drug Candidate,” Biochemical and Biophysical Research Communications 508, no. 2 (2019): 451–457, 10.1016/j.bbrc.2018.11.120. [DOI] [PubMed] [Google Scholar]
- 37. Konakanchi S., Raavi V., and Shankar M. V., “Impact of Chronic Sleep Deprivation and Sleep Recovery on Hippocampal Oligodendrocytes, Anxiety‐Like Behavior, Spatial Learning and Memory of Rats,” Brain Research Bulletin 193 (2023): 59–71. [DOI] [PubMed] [Google Scholar]
- 38. Massadeh A. M., Alzoubi K. H., Milhem A. M., Rababa'h A. M., and Khabour O. F., “Evaluating the Effect of Selenium on Spatial Memory Impairment Induced by Sleep Deprivation,” Physiology & Behavior 244 (2022): 113669, 10.1016/j.physbeh.2021.113669. [DOI] [PubMed] [Google Scholar]
- 39. Wang C., Cui W., Yu B., et al., “Role of Succinylation Modification in Central Nervous System Diseases,” Ageing Research Reviews 95 (2024): 102242, 10.1016/j.arr.2024.102242. [DOI] [PubMed] [Google Scholar]
- 40. Yang N., Li L., Shi X. L., et al., “Succinylation of SERCA2a at K352 Promotes Its Ubiquitinoylation and Degradation by Proteasomes in Sepsis‐Induced Heart Dysfunction,” Circulation. Heart Failure 18, no. 4 (2025): e012180, 10.1161/CIRCHEARTFAILURE.124.012180. [DOI] [PubMed] [Google Scholar]
- 41. Tsimokha A. S., Artamonova T. O., Diakonov E. E., Khodorkovskii M. A., and Tomilin A. N., “Post‐Translational Modifications of Extracellular Proteasome,” Molecules 25, no. 15 (2020): 3504, 10.3390/molecules25153504. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Xu H., Zhou J., Lin S., Deng W., Zhang Y., and Xue Y., “PLMD: An Updated Data Resource of Protein Lysine Modifications,” Journal of Genetics and Genomics 44, no. 5 (2017): 243–250, 10.1016/j.jgg.2017.03.007. [DOI] [PubMed] [Google Scholar]
- 43. Colrain I. M., “Sleep and the Brain,” Neuropsychology Review 21, no. 1 (2011): 1–4, 10.1007/s11065-011-9156-z. [DOI] [PubMed] [Google Scholar]
- 44. Palagini L., Hertenstein E., Riemann D., and Nissen C., “Sleep, Insomnia and Mental Health,” Journal of Sleep Research 31, no. 4 (2022): e13628, 10.1111/jsr.13628. [DOI] [PubMed] [Google Scholar]
- 45. Zamore Z. and Veasey S. C., “Neural Consequences of Chronic Sleep Disruption,” Trends in Neurosciences 45, no. 9 (2022): 678–691, 10.1016/j.tins.2022.05.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Xu X., Wang L., Zhang Y., et al., “Effects of Chronic Sleep Deprivation on Glucose Homeostasis in Rats,” Sleep and Biological Rhythms 14, no. 4 (2016): 321–328, 10.1007/s41105-016-0061-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Lin J., Luo F., Han S., Xia M., Chen Z., and Liu P., “Study on the Mechanism of Hydrolyzed Seawater Pearl Tablet in Treating Chronic Sleep Deprivation Mice Model,” Endocrine, Metabolic & Immune Disorders Drug Targets 23, no. 7 (2023): 927–936, 10.2174/1871530323666230206160722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Konakanchi S., Raavi V., and Shankar M. V., “Effect of Chronic Sleep Deprivation and Sleep Recovery on Hippocampal CA3 Neurons, Spatial Memory and Anxiety‐Like Behavior in Rats,” Neurobiology of Learning and Memory 187 (2022): 107559. [DOI] [PubMed] [Google Scholar]
- 49. Alzoubi K. H., Mayyas F., and Abu Zamzam H. I., “Omega‐3 Fatty Acids Protects Against Chronic Sleep‐Deprivation Induced Memory Impairment,” Life Sciences 227 (2019): 1–7, 10.1016/j.lfs.2019.04.028. [DOI] [PubMed] [Google Scholar]
- 50. Radcliffe P. N., Whitney C. C., Fagnant H. S., et al., “Severe Sleep Restriction Suppresses Appetite Independent of Effects on Appetite Regulating Hormones in Healthy Young Men Without Obesity,” Physiology & Behavior 237 (2021): 113438, 10.1016/j.physbeh.2021.113438. [DOI] [PubMed] [Google Scholar]
- 51. Galvão M. O., Sinigaglia‐Coimbra R., Kawakami S. E., Tufik S., and Suchecki D., “Paradoxical Sleep Deprivation Activates Hypothalamic Nuclei That Regulate Food Intake and Stress Response,” Psychoneuroendocrinology 34, no. 8 (2009): 1176–1183, 10.1016/j.psyneuen.2009.03.003. [DOI] [PubMed] [Google Scholar]
- 52. Rohrback S., Siddoway B., Liu C. S., and Chun J., “Genomic Mosaicism in the Developing and Adult Brain,” Developmental Neurobiology 78, no. 11 (2018): 1026–1048, 10.1002/dneu.22626. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Milenkovic I., Blumenreich S., and Futerman A. H., “GBA Mutations, Glucosylceramide and Parkinson's Disease,” Current Opinion in Neurobiology 72 (2022): 148–154, 10.1016/j.conb.2021.11.004. [DOI] [PubMed] [Google Scholar]
- 54. Ganesh R. A., Venkataraman K., and Sirdeshmukh R., “GPR56: An Adhesion GPCR Involved in Brain Development, Neurological Disorders and Cancer,” Brain Research 1747 (2020): 147055, 10.1016/j.brainres.2020.147055. [DOI] [PubMed] [Google Scholar]
- 55. Thaler A., Ash E., Gan‐Or Z., Orr‐Urtreger A., and Giladi N., “The LRRK2 G2019S Mutation as the Cause of Parkinson's Disease in Ashkenazi Jews,” Journal of Neural Transmission 116, no. 11 (2009): 1473–1482, 10.1007/s00702-009-0303-0. [DOI] [PubMed] [Google Scholar]
- 56. Nixon R. A. and Sihag R. K., “Neurofilament Phosphorylation: A New Look at Regulation and Function,” Trends in Neurosciences 14, no. 11 (1991): 501–506, 10.1016/0166-2236(91)90062-Y. [DOI] [PubMed] [Google Scholar]
- 57. Goldstein M. E., Sternberger N. H., and Sternberger L. A., “Phosphorylation Protects Neurofilaments Against Proteolysis,” Journal of Neuroimmunology 14, no. 2 (1987): 149–160, 10.1016/0165-5728(87)90049-X. [DOI] [PubMed] [Google Scholar]
- 58. Pant H. C., “Dephosphorylation of Neurofilament Proteins Enhances Their Susceptibility to Degradation by Calpain,” Biochemical Journal 256, no. 2 (1988): 665–668, 10.1042/bj2560665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. He Q., Ji L., Wang Y., et al., “Acetate Enables Metabolic Fitness and Cognitive Performance During Sleep Disruption,” Cell Metabolism 36, no. 9 (2024): 1998–2014.e1915, 10.1016/j.cmet.2024.07.019. [DOI] [PubMed] [Google Scholar]
- 60. Kim S. A., Kim S., and Park H. J., “REM‐Sleep Deprivation Induces Mitochondrial Biogenesis in the Rat Hippocampus,” In Vivo 36, no. 4 (2022): 1726–1733, 10.21873/invivo.12885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Kim J.‐H., Kim J.‐H., Cho Y.‐E., et al., “Chronic Sleep Deprivation‐Induced Proteome Changes in Astrocytes of the Rat Hypothalamus,” Journal of Proteome Research 13, no. 9 (2014): 4047–4061, 10.1021/pr500431j. [DOI] [PubMed] [Google Scholar]
- 62. Ozathaley A., Kou Z., Ma Y., et al., “NLRP3 Upregulation Related to Sleep Deprivation‐Induced Memory and Emotional Behavior Changes in TRPV1(−/−) Mice,” Behavioural Brain Research 440 (2023): 114255, 10.1016/j.bbr.2022.114255. [DOI] [PubMed] [Google Scholar]
- 63. Ang G., McKillop L. E., Purple R., et al., “Absent Sleep EEG Spindle Activity in GluA1 (Gria1) Knockout Mice: Relevance to Neuropsychiatric Disorders,” Translational Psychiatry 8, no. 1 (2018): 154, 10.1038/s41398-018-0199-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Benvegnù S., Mateo M. I., Palomer E., Jurado‐Arjona J., and Dotti C. G., “Aging Triggers Cytoplasmic Depletion and Nuclear Translocation of the E3 Ligase Mahogunin: A Function for Ubiquitin in Neuronal Survival,” Molecular Cell 66, no. 3 (2017): 358–372, 10.1016/j.molcel.2017.04.005. [DOI] [PubMed] [Google Scholar]
- 65. Meier‐Ewert H. K., Ridker P. M., Rifai N., et al., “Effect of Sleep Loss on C‐Reactive Protein, an Inflammatory Marker of Cardiovascular Risk,” Journal of the American College of Cardiology 43, no. 4 (2004): 678–683, 10.1016/j.jacc.2003.07.050. [DOI] [PubMed] [Google Scholar]
- 66. Zeng S., Liu N., Zhang A., Duan N., Xu B., and Ai C., “Molecular Basis Identification and Hypnotic Drug Interactions for Cognitive Impairment Related to Sleep Deprivation,” BMC Psychiatry 25, no. 1 (2025): 371, 10.1186/s12888-024-06395-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Mizutani H., Sato Y., Yamazaki M., et al., “SIRT7 Deficiency Protects Against Aβ42‐Induced Apoptosis Through the Regulation of NOX4‐Derived Reactive Oxygen Species Production in SH‐SY5Y Cells,” International Journal of Molecular Sciences 23, no. 16 (2022): 9027, 10.3390/ijms23169027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Zhang X., Di Y., Wang Y., et al., “SIRT5‐Mediated Desuccinylation of PPA2 Enhances HIF‐1alpha‐Dependent Adaptation to Hypoxic Stress and Colorectal Cancer Metastasis,” EMBO Journal 44, no. 9 (2025): 2514–2540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Veverová K., Laczó J., Katonová A., et al., “Alterations of Human CSF and Serum‐Based Mitophagy Biomarkers in the Continuum of Alzheimer Disease,” Autophagy 20, no. 8 (2024): 1868–1878, 10.1080/15548627.2024.2340408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Zhang T., Tang Y., Yang X., et al., “Expression of GSK3β, PICK1, NEFL, C4, NKCC1 and Synaptophysin in Peripheral Blood Mononuclear Cells of the First‐Episode Schizophrenia Patients,” Asian Journal of Psychiatry 55 (2021): 102520, 10.1016/j.ajp.2020.102520. [DOI] [PubMed] [Google Scholar]
- 71. Zhu S., Su L., Zhuang M., et al., “NEFL Modulates NRN1‐Mediated Mitochondrial Pathway to Promote Diacetylmorphine‐Induced Neuronal Apoptosis,” Molecular Neurobiology 62, no. 6 (2024): 6983–6997, 10.1007/s12035-024-04629-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Cao M., Fang Y., Jia W., Wang Y., Sun J., and Tao D., “Emodin Relieves Hypoxia‐Triggered Injury via Elevation of microRNA‐25 in PC‐12 Cells,” Artificial Cells, Nanomedicine, and Biotechnology 47, no. 1 (2019): 2678–2687, 10.1080/21691401.2019.1633339. [DOI] [PubMed] [Google Scholar]
- 73. Liu C., Tian Q., Li Z., et al., “FOXO3a‐BAP1 Axis Regulates Neuronal Ferroptosis in Early Brain Injury After Subarachnoid Hemorrhage,” Redox Biology 82 (2025): 103550, 10.1016/j.redox.2025.103550. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 74. Tian Q., Liu C., Liao J., et al., “ATF2/BAP1 Axis Mediates Neuronal Apoptosis After Subarachnoid Hemorrhage via P53 Pathway,” Stroke 55, no. 8 (2024): 2113–2125, 10.1161/STROKEAHA.123.045781. [DOI] [PubMed] [Google Scholar]
- 75. Campagne A., Lee M. K., Zielinski D., et al., “BAP1 Complex Promotes Transcription by Opposing PRC1‐Mediated H2A Ubiquitylation,” Nature Communications 10, no. 1 (2019): 348, 10.1038/s41467-018-08255-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Figure S1: CSD changed the succinylomics of rats.
Figure S2: Western blot was used to detect the level of myc‐NFL.
Data Availability Statement
The Proteomics analysis results were deposited in the PRoteomics IDEntifications Database (PRIDE, https://www.ebi.ac.uk/pride/). The accession numbers included PXD071915 (label‐free proteomics), PXD071510 (ubiquitinomics), and PXD071630 (succinylomics).
